Abstract | BACKGROUND: PATIENTS AND METHODS: We performed an open-label, pilot study on three young patients, coming from the same kindred, with hereditary pancreatitis. The study period lasted two years (July 1997-July 1999) and was divided into four sub-periods of six months each. In the first and third period the patients took only oral analgesics, if necessary; in the second and fourth period, an antioxidant regimen per os was added. This treatment consisted of sulphadenosyl- methionine (800 mg per day), Vitamin C (180 mg per day), Vitamin E (30 mg per day), Vitamin A (2,400 microg per day), and selenium (75 microg per day). RESULTS: Compliance of patients to the treatment schedule was satisfactory and no important side-effects were observed. Antioxidant treatment led to a significant reduction (p<0.05) in the number of days with abdominal pain experienced by the three patients and this was verified for both periods of treatment. Albeit, consumption of analgesics was lower in the antioxidant treatment periods. CONCLUSIONS:
|
Authors | G Uomo, G Talamini, P G Rabitti |
Journal | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
(Dig Liver Dis)
2001 Jan-Feb
Vol. 33
Issue 1
Pg. 58-62
ISSN: 1590-8658 [Print] Netherlands |
PMID | 11303976
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Abdominal Pain
(drug therapy)
- Adolescent
- Amino Acid Substitution
(genetics)
- Antioxidants
(administration & dosage)
- Child
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Male
- Mutation
- Pain Measurement
- Pancreatitis
(drug therapy, genetics)
- Pilot Projects
- Trypsinogen
(genetics)
|